IL15 and neoplasm: Also, NKG2D-CAR-engineered NKAR-NK-92 and NKAR_RD-IL15-NK-92 cells effectively lysed tumor cells that expressed natural NKG2D ligands in the absence of the bispecific killer cell engagers.